Certican

Certican (Everolimus) is an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication helps manage the body's immune response, ensuring compatibility with transplanted organs.

Certican is primarily used to prevent organ rejection in patients who have undergone liver or kidney transplants. It works by suppressing the immune system's response to the new organ, reducing the risk of rejection. Everolimus is often part of a broader treatment plan that may include other immunosuppressants.

Common effects of Certican may include headaches, nausea, and fatigue. Some users might experience swelling or infections due to the medication's impact on the immune system. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Certican should be handled with care, especially regarding dosage and administration. It is crucial to follow the prescribed regimen to avoid complications. Patients should inform their healthcare provider about any pre-existing conditions or other medications they are taking to ensure safe use.

Certican may interact with other medications, particularly those that affect the liver's enzyme activity. Alcohol and certain foods can also influence its effectiveness. It's advisable to discuss potential interactions with a healthcare professional before starting Certican.